Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

Susan J. Bartlett, Vivian P. Bykerk, Roxanne Cooksey, Ernest H. Choy, Rieke Alten, Robin Christensen, Daniel E. Furst, Francis Guillemin, Serena Halls, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn March, Pamela Montie, Ana Maria Orbai, Christoph Pohl, Marieke Scholte Voshaar, Thasia G. Woodworth and Clifton O. Bingham 3rd
The Journal of Rheumatology November 2015, 42 (11) 2185-2189; DOI: https://doi.org/10.3899/jrheum.141169
Susan J. Bartlett
From McGill University, Montreal, Quebec, Canada; Johns Hopkins University, Baltimore, Maryland; Hospital for Special Surgery, New York, New York, USA; Swansea University, Swansea; Cardiff University, Cardiff, UK; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany; The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen, Denmark; University of California, Los Angeles, California, USA; University of Lorraine, Nancy, France; University of the West of England, Bristol, UK; Healthy Motivation, Santa Barbara, California, USA; University of Sydney, Sydney, Australia; and University of Twente, Enschede, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Susan.bartlett{at}mcgill.ca
Vivian P. Bykerk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roxanne Cooksey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernest H. Choy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rieke Alten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel E. Furst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis Guillemin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serena Halls
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Hewlett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amye L. Leong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Lyddiatt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyn March
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela Montie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Maria Orbai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Pohl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marieke Scholte Voshaar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thasia G. Woodworth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifton O. Bingham 3rd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Alten R,
    2. Pohl C,
    3. Choy EH,
    4. Christensen R,
    5. Furst DE,
    6. Hewlett SE,
    7. et al.
    Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. J Rheumatol 2011;38:1745–50.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Bingham CO 3rd,
    2. Alten R,
    3. Bartlett SJ,
    4. Bykerk VP,
    5. Brooks PM,
    6. Choy E,
    7. et al.
    Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol 2011;38:1751–8.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bingham CO III,
    2. Pohl C,
    3. Alten R,
    4. Christensen R,
    5. Choy EH,
    6. Hewlett SE,
    7. et al.
    Flare and disease worsening in rheumatoid arthritis: time for a definition. Int J Adv Rheumatol 2009;7:85–91.
    OpenUrl
  4. 4.↵
    1. Bykerk VP,
    2. Lie E,
    3. Bartlett SJ,
    4. Alten R,
    5. Boonen A,
    6. Christensen R,
    7. et al.
    Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol 2014;41:799–809.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Bingham CO 3rd,
    2. Pohl C,
    3. Woodworth TG,
    4. Hewlett SE,
    5. May JE,
    6. Rahman MU,
    7. et al.
    Developing a standardized definition for disease “flare” in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 2009;36:2335–41.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Smolen JS,
    2. Aletaha D,
    3. Bijlsma JW,
    4. Breedveld FC,
    5. Boumpas D,
    6. Burmester G,
    7. et al.
    Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Singh JA,
    2. Furst DE,
    3. Bharat A,
    4. Curtis JR,
    5. Kavanaugh AF,
    6. Kremer JM,
    7. et al.
    2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625–39.
    OpenUrlCrossRef
  8. 8.↵
    1. van der Maas A,
    2. den Broeder AA
    . Measuring flares in rheumatoid arthritis. (Why) do we need validated criteria? J Rheumatol 2014;41:189–91.
    OpenUrlFREE Full Text
  9. 9.↵
    1. Hewlett S,
    2. Sanderson T,
    3. May J,
    4. Alten R,
    5. Bingham CO III,
    6. Cross M,
    7. et al.
    ‘I’m hurting, I want to kill myself’: rheumatoid arthritis flare is more than a high joint count—an international patient perspective on flare where medical help is sought. Rheumatology 2012;51:69–76.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Bartlett SJ,
    2. Hewlett S,
    3. Bingham CO 3rd,
    4. Woodworth TG,
    5. Alten R,
    6. Pohl C,
    7. et al.
    Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis 2012;71:1855–60.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Berthelot JM,
    2. De Bandt M,
    3. Morel J,
    4. Benatig F,
    5. Constantin A,
    6. Gaudin P,
    7. et al.
    A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: The ‘FLARE’ instrument. Ann Rheum Dis 2012;71:1110–6.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Bingham CO 3rd,
    2. Alten R,
    3. de Wit MP
    . The importance of patient participation in measuring rheumatoid arthritis flares. Ann Rheum Dis 2012;71:1107–9.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Gossec L,
    2. Dougados M,
    3. Rincheval N,
    4. Balanescu A,
    5. Boumpas DT,
    6. Canadelo S,
    7. et al.
    Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680–5.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Sanderson T,
    2. Morris M,
    3. Calnan M,
    4. Richards P,
    5. Hewlett S
    . What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res 2010;62:640–6.
    OpenUrlCrossRef
  15. 15.↵
    1. Felson DT,
    2. Anderson JJ,
    3. Boers M,
    4. Bombardier C,
    5. Furst D,
    6. Goldsmith C,
    7. et al.
    American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727–35.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Kirwan JR,
    2. Bartlett SJ,
    3. Beaton DE,
    4. Boers M,
    5. Bosworth A,
    6. Brooks PM,
    7. et al.
    Updating the OMERACT filter: implications for patient-reported outcomes. J Rheumatol 2014;41:1011–5.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Tugwell P,
    2. Boers M,
    3. D’Agostino MA,
    4. Beaton D,
    5. Boonen A,
    6. Bingham CO 3rd,
    7. et al.
    Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of “truth”: content, face, and construct validity. J Rheumatol 2014;41:1000–4.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. de Vet HCW,
    2. Terwee CB,
    3. Mokkink LB,
    4. Knol DL
    . Measurement in medicine: a practical guide. Cambridge, UK: Cambridge University Press; 2011.
  19. 19.↵
    1. Bykerk VP,
    2. Jamal S,
    3. Boire G,
    4. Hitchon CA,
    5. Haraoui B,
    6. Pope JE,
    7. et al.
    The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. J Rheumatol 2012;39:2071–80.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. van der Maas A,
    2. Lie E,
    3. Christensen R,
    4. Choy E,
    5. de Man YA,
    6. van Riel P,
    7. et al.
    Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study. Ann Rheum Dis 2013;72:1800–5.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. den Broeder AA,
    2. van Herwaarden N,
    3. van der Maas A,
    4. van den Hoogen FH,
    5. Bijlsma JW,
    6. van Vollenhoven RF,
    7. et al.
    Dose reduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study. BMC Musculoskelet Disord 2013;14:299.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Orbai AM,
    2. Smith KC,
    3. Bartlett SJ,
    4. De Leon E,
    5. Bingham CO 3rd.
    “Stiffness has different meanings, I think, to everyone”: examining stiffness from the perspective of people living with rheumatoid arthritis. Arthritis Care Res 2014;66:1662–72.
    OpenUrlCrossRef
  23. 23.↵
    1. Halls S,
    2. Dures E,
    3. Kirwan J,
    4. Pollock J,
    5. Baker G,
    6. Edmunds A,
    7. et al.
    Stiffness is more than just duration and severity: a qualitative exploration in people with rheumatoid arthritis. Rheumatology 2014; Sept 16 (E-pub ahead of print).
  24. 24.↵
    1. Orbai AM,
    2. Halls S,
    3. Hewlett S,
    4. Bartlett S,
    5. Leong A,
    6. Bingham CO 3rd.
    More than just minutes of stiffness in the morning: report from the OMERACT rheumatoid arthritis flare group stiffness breakout sessions. J Rheumatol 2015;42:2182–4.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Boers M,
    2. Idzerda L,
    3. Kirwan JR,
    4. Beaton D,
    5. Escorpizo R,
    6. Boonen A,
    7. et al.
    Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11. J Rheumatol 2014;41:978–85.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 11
1 Nov 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary
Susan J. Bartlett, Vivian P. Bykerk, Roxanne Cooksey, Ernest H. Choy, Rieke Alten, Robin Christensen, Daniel E. Furst, Francis Guillemin, Serena Halls, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn March, Pamela Montie, Ana Maria Orbai, Christoph Pohl, Marieke Scholte Voshaar, Thasia G. Woodworth, Clifton O. Bingham
The Journal of Rheumatology Nov 2015, 42 (11) 2185-2189; DOI: 10.3899/jrheum.141169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary
Susan J. Bartlett, Vivian P. Bykerk, Roxanne Cooksey, Ernest H. Choy, Rieke Alten, Robin Christensen, Daniel E. Furst, Francis Guillemin, Serena Halls, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn March, Pamela Montie, Ana Maria Orbai, Christoph Pohl, Marieke Scholte Voshaar, Thasia G. Woodworth, Clifton O. Bingham
The Journal of Rheumatology Nov 2015, 42 (11) 2185-2189; DOI: 10.3899/jrheum.141169
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

FLARE
DISEASE EXACERBATION
RHEUMATOID ARTHRITIS
OMERACT

Related Articles

Cited By...

More in this TOC Section

OMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

  • Development and Preliminary Validation of a Digital Overlay-based Learning Module for Semiquantitative Evaluation of Magnetic Resonance Imaging Lesions in Osteoarthritis of the Hip
  • Minimal Clinically Important Difference as Applied in Rheumatology: An OMERACT Rasch Working Group Systematic Review and Critique
  • Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter — Determining Validation Requirements
Show more OMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

Part 2: Working Groups

  • Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody–associated Vasculitis Using the OMERACT Process
  • Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014
Show more Part 2: Working Groups

Similar Articles

Keywords

  • flare
  • DISEASE EXACERBATION
  • rheumatoid arthritis
  • OMERACT

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire